Skip to main content

Orserdu Disease Interactions

There is 1 disease interaction with Orserdu (elacestrant).

Moderate

Elacestrant (applies to Orserdu) liver dysfunction

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease

Avoid the use of elacestrant in patients with severe hepatic impairment (Child-Pugh C). The dose should be reduced in patients with moderate hepatic impairment (Child-Pugh B). No dosage adjustment is
recommended for patients with mild hepatic impairment (Child-Pugh A).

References

  1. (2022) "Product Information. Vancocin (vancomycin)." Aspen Pharmacare Australia Pty Ltd

Orserdu drug interactions

There are 225 drug interactions with Orserdu (elacestrant).

Orserdu alcohol/food interactions

There is 1 alcohol/food interaction with Orserdu (elacestrant).

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer